- Home
- KZIA vs SMTK Comparison
KZIA vs SMTK Comparison
Compare KZIA & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- SMTK
- Stock Information
- Founded
- KZIA 1994
- SMTK 2009
- Country
- KZIA Australia
- SMTK United Kingdom
- Employees
- KZIA N/A
- SMTK N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- SMTK
- Sector
- KZIA Health Care
- SMTK
- Exchange
- KZIA Nasdaq
- SMTK NYSE
- Market Cap
- KZIA 5.1M
- SMTK 6.1M
- IPO Year
- KZIA 1999
- SMTK N/A
- Fundamental
- Price
- KZIA $10.45
- SMTK $0.97
- Analyst Decision
- KZIA Strong Buy
- SMTK
- Analyst Count
- KZIA 2
- SMTK 0
- Target Price
- KZIA $14.00
- SMTK N/A
- AVG Volume (30 Days)
- KZIA 745.7K
- SMTK 192.5K
- Earning Date
- KZIA 07-22-2025
- SMTK 08-11-2025
- Dividend Yield
- KZIA N/A
- SMTK N/A
- EPS Growth
- KZIA N/A
- SMTK N/A
- EPS
- KZIA N/A
- SMTK N/A
- Revenue
- KZIA $1,549,158.00
- SMTK $105,000.00
- Revenue This Year
- KZIA N/A
- SMTK N/A
- Revenue Next Year
- KZIA N/A
- SMTK N/A
- P/E Ratio
- KZIA N/A
- SMTK N/A
- Revenue Growth
- KZIA 248983.08
- SMTK 854.54
- 52 Week Low
- KZIA $2.86
- SMTK $0.78
- 52 Week High
- KZIA $79.00
- SMTK $7.80
- Technical
- Relative Strength Index (RSI)
- KZIA 72.75
- SMTK N/A
- Support Level
- KZIA $5.86
- SMTK N/A
- Resistance Level
- KZIA $7.20
- SMTK N/A
- Average True Range (ATR)
- KZIA 1.17
- SMTK 0.00
- MACD
- KZIA 0.15
- SMTK 0.00
- Stochastic Oscillator
- KZIA 82.21
- SMTK 0.00
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in several applications, including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.